Ryan S. Napierski - 27 Feb 2023 Form 4 Insider Report for NU SKIN ENTERPRISES, INC. (NUS)

Role
President and CEO, Director
Signature
/s/ Gregory Belliston as Attorney-in-Fact for Ryan S. Napierski
Issuer symbol
NUS
Transactions as of
27 Feb 2023
Net transactions value
-$329,119
Form type
4
Filing time
28 Feb 2023, 18:46:52 UTC
Previous filing
23 Feb 2023
Next filing
14 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUS Class A Common Stock Options Exercise $658,943 +21,513 +13% $30.63 190,297 27 Feb 2023 Direct
transaction NUS Class A Common Stock Sale $890,208 -21,513 -11% $41.38 168,784 27 Feb 2023 Direct F1, F2
transaction NUS Class A Common Stock Options Exercise $306,300 +10,000 +5.9% $30.63 178,784 28 Feb 2023 Direct
transaction NUS Class A Common Stock Sale $379,572 -9,400 -5.3% $40.38 169,384 28 Feb 2023 Direct F3
transaction NUS Class A Common Stock Sale $24,582 -600 -0.35% $40.97 168,784 28 Feb 2023 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUS Employee Stock Option (Right to Buy) Options Exercise $0 -2,513 -20% $0.000000 10,000 27 Feb 2023 Class A Common Stock 2,513 $30.63 Direct F5
transaction NUS Employee Stock Option (Right to Buy) Options Exercise $0 -19,000 -100% $0.000000* 0 27 Feb 2023 Class A Common Stock 19,000 $30.63 Direct F5
transaction NUS Employee Stock Option (Right to Buy) Options Exercise $0 -10,000 -100% $0.000000* 0 28 Feb 2023 Class A Common Stock 10,000 $30.63 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale pursuant to a 10b5-1 plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.85 to $41.66, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.89 to $40.86, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.91 to $41.02, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
F5 Currently exercisable in full.